Skip to main content
OpenTrials

Clinical trial condition

PDAC

Explore clinical trials studying PDAC. Study availability and eligibility vary by location and protocol.

22 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

PDAC trial results

Recruiting

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

NCT06922591

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Sarah Cannon Research Institute Denver Denver, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 18 locations
View Trial Details
Recruiting

IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors

NCT07441174

Conditions
PDAC, Solid Tumor Cancer
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View all 14 locations
View Trial Details
Recruiting

A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation

NCT07259590

Conditions
Advanced Solid Tumors Cancer, CRC (Colorectal Cancer), Colonic Diseases, +11 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Not yet recruiting

The Canopy Cancer Collective Clinical Registry Protocol

NCT07605702

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +18 more
Locations
  • UC San Diego Health San Diego, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Active, not recruiting

ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer

NCT05355298

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • GenesisCare St Leonards, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Gallipolli Medical Research Foundation Greenslopes, Queensland, Australia
View all 13 locations
View Trial Details

Related conditions